Silva Pharmaceuticals (DHA:SILVAPHL) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Silva Pharmaceuticals COGS-to-Revenue?

Silva Pharmaceuticals's Cost of Goods Sold for the six months ended in . 20 was BDT0.00 Mil. Its Revenue for the six months ended in . 20 was BDT0.00 Mil.

Silva Pharmaceuticals's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Silva Pharmaceuticals's Gross Margin % for the six months ended in . 20 was N/A%.

Silva Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Silva Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silva Pharmaceuticals COGS-to-Revenue Chart

Silva Pharmaceuticals Annual Data

Trend

COGS-to-Revenue

Silva Pharmaceuticals Semi-Annual Data

COGS-to-Revenue

Silva Pharmaceuticals COGS-to-Revenue Calculation

Silva Pharmaceuticals's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Silva Pharmaceuticals's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Silva Pharmaceuticals (DHA:SILVAPHL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Silva Pharmaceuticals's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Silva Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Silva Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Silva Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silva Pharmaceuticals Ltd (DHA:SILVAPHL) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road No 8/A New, House No 65, Dhanmondi, Dhaka, BGD, 1209

Website

https://www.silvapharma.com

Silva Pharmaceuticals Ltd is engaged in the manufacturing and marketing of pharmaceuticals finished products. The products are manufactured in the categories of Antibiotics, Analgesics, Antidiabetics, Narcotics, Anti pyretic, Antiinflammatory Drugs, Anti ulcerates, Antiemetic, Gastroprokinetic, Antihistamine, Antispasmodic expectorants, Vitamins, and Minerals medicines. The products are sold in the local market of Bangladesh.

Silva Pharmaceuticals Headlines

No Headlines